Diabetes is a chronic health condition affecting blood glucose levels. In some cases, it requires constant management in the form of monitoring blood glucose levels and administering insulin.
Insulet (PODD) is the first and only company to offer a tubeless automated insulin delivery (AID) system with full control from a compatible iPhone or Android™ phone Provides more choice and added ...
If you have type 1 diabetes, you know how difficult it can feel to manage your insulin levels and track your progress over time without turning it into something that resembles a full-time job. And ...
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today presented ...
Insulet Corporation PODD recently announced positive results from the first pivotal study for the Omnipod 5 Automated Insulin Delivery System. The finding of the study suggests that Omnipod 5 ...
Ongoing efforts from several fronts are aimed at convincing the US Centers for Medicare and Medicaid Services (CMS) to change its coverage plans for Medicare, which currently exclude several diabetes ...
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the full market release ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback